Research Topics
| Jane ZuckermanSummaryAffiliation: University College London Country: UK Publications
|
Detail Information
Publications
2010 FIFA world cup South Africa: travel health issues and new options for protection against meningococcal diseaseJane N Zuckerman
Academic Centre for Travel Medicine and Vaccines, WHO Collaborating Centre for Reference, Research and Training in Travel Medicine, University College London Medical School, Rowland Hill Street, London NW3 2PF, United Kingdom
Travel Med Infect Dis 8:68-73. 2010..The conjugated quadrivalent meningococcal vaccine should be recommended for all those attending or playing in the 2010 FIFA World Cup South Africa as well as similar global and regional events...- Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: retrospective observational dataJane N Zuckerman
WHO Collaborating Centre for Reference, Research and Training in Travel Medicine, University College London Medical School, London, UK
Travel Med Infect Dis 7:329-36. 2009..Further work is required to ascertain whether ease of use and compliance may be important factors in the outcomes associated with malaria chemoprophylaxis... - Hepatitis B immunisation in travellers: poor risk perception and inadequate protectionJane N Zuckerman
WHO Collaborating Centre for Travel Medicine, The Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill St, London, NW3 2PF, UK
Travel Med Infect Dis 6:315-20. 2008..A survey of European travellers was conducted during 2006 to determine travellers' immunisation status and risk for exposure to hepatitis B while travelling... 
The true burden and risk of cholera: implications for prevention and controlJane N Zuckerman
Academic Centre for Travel Medicine and Vaccines, WHO Collaborating Centre for Travel Medicine, Royal Free and University College Medical School, London, UK
Lancet Infect Dis 7:521-30. 2007..However, a vaccine against cholera is now available that has proven efficacy and tolerability in mass vaccination campaigns in low-income countries, and among travellers...- Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?Jane Zuckerman
Academic Centre for Travel Medicine and Vaccines, WHO Collaborating Centre for Travel Medicine, Royal Free and University College Medical School, London, UK
Lancet Infect Dis 7:410-9. 2007..Universal vaccination against hepatitis B is the only way to eliminate the major public-health impact of this disease... - Review: hepatitis B immune globulin for prevention of hepatitis B infectionJ N Zuckerman
Academic Centre for Travel Medicine and Vaccines, WHO Collaborating Centre for Reference, Research and Training in Travel Medicine, Royal Free and University College Medical School, University College London, UK
J Med Virol 79:919-21. 2007.... - Vaccination against hepatitis A and B: developments, deployment and delusionsJane N Zuckerman
Academic Centre for Travel Medicine and Vaccines and the WHO Collaborating Centre for Reference, Research and Training in Travel Medicine, Royal Free and University College Medical School, London, UK
Curr Opin Infect Dis 19:456-9. 2006.... - Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccinesJane N Zuckerman
Academic Centre for Travel Medicine and Vaccines and WHO Collaborating Centre for Reference, Research and Training in Travel Medicine, Royal Free and University College Medical School, University College London, United Kingdom
J Med Virol 78:169-77. 2006.... - Hepatitis A and B booster recommendations: implications for travelersJane N Zuckerman
Academic Centre for Travel Medicine and Vaccines and Royal Free Travel Health Centre, World Health Organization Collaborating Centre for Travel Medicine, Royal Free and University College Medical School, London, United Kingdom
Clin Infect Dis 41:1020-6. 2005..However, for the majority of immunocompetent travelers, the full primary vaccination course will provide protection from both hepatitis A and B infection in the long term, without the need for boosters... - Hepatitis B vaccination in a school age population: a feasibility studyJane Zuckerman
Academic Centre for Travel Medicine and Vaccines, WHO Collaborating Centre for Reference, Research and Training in Travel Medicine, Royal Free and University College Medical School, London, United Kingdom
J Med Virol 76:47-54. 2005..A further requirement includes the availability of good local health support within schools so as to allow for an efficient vaccine delivery system to maximize vaccination in this setting... - The place of accelerated schedules for hepatitis A and B vaccinationsJane Zuckerman
Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK
Drugs 63:1779-84. 2003..The primary course may be administered within a period of 1 month so providing protection for those at risk and, in particular, the last minute traveller... 
Recent developments: Travel medicineJane N Zuckerman
Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, London NW3 2PF
BMJ 325:260-4. 2002- Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotidesNigel J Temperton
Department of Virology, Royal Free and University College Medical School, London, United Kingdom
J Med Virol 70:86-90. 2003..The results provide a rationale for evaluating combinations of other HCMV proteins for incorporation into a multi-target DNA vaccine, and for the optimization of adjuvant usage, to elicit enhanced levels of neutralizing antibodies. 2003... - Vaccination priorities in travelJane N Zuckerman
Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, University College London, London, UK
BioDrugs 17:1-6. 2003 - Recombinant hepatitis B triple antigen vaccine: HepacareJane N Zuckerman
Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, University College of London, UK
Expert Rev Vaccines 1:141-4. 2002..The triple antigen is indicated for vaccination of nonresponders (and hyporesponders) to the current single antigen vaccines and for persons who require rapid protection against hepatitis B infection... - Mutations of the surface protein of hepatitis B virusJane N Zuckerman
Research and Training in Travel Medicine, Royal Free and University College Medical School, University College London, London, UK
Antiviral Res 60:75-8. 2003..There is evidence that these mutants may not be detected by current screening tests and diagnostic reagents. Epidemiological monitoring of hepatitis B virus surface mutants is essential... - HIV and travelM A Schuhwerk
Department of Genito Urinary Medicine, Mortimer Market Centre, Camden Primary Care Trust NHS, London, UK
Travel Med Infect Dis 4:174-83. 2006..A wide range of relevant issues for the HIV-positive traveller are discussed in this review and useful websites can be found at the end... - Impact of the insect biting nuisance on a British youth expedition to AlaskaFiona J Cooke
Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, London, United Kingdom
J Travel Med 9:76-81. 2002..Thus, it is recommended that expeditions and independent travelers to this area do not need to increase time spent in the field to compensate for expedition man days lost due to problems associated with the insect biting nuisance... - Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patientsFrederik Nevens
Department of Hepatology, University Hospital Gasthuisberg K U Leuven, Leuven, Belgium
Liver Transpl 12:1489-95. 2006..Liver transplant candidates could benefit from the use of this experimental adjuvanted HB vaccine to further increase their protection against HB infection... - Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccinesHans D Nothdurft
Department of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians University, Munich, Germany
BioDrugs 17:15-8. 2003 - Introduction to the Second International Conference of the Journal of Travel Medicine and Infectious DiseaseJane N Zuckerman
Travel Med Infect Dis 6:171-2. 2008 - Imported malaria in the UKJane N Zuckerman
BMJ 337:a135. 2008 - Preventing malaria in UK travellersJane N Zuckerman
BMJ 329:305-6. 2004 - Vaccine advice for travellersJane N Zuckerman
Academic Centre for Travel Medicine and Vaccines
Practitioner 249:286-90. 2005